参考文献/References:
[1] CedenoLaurent F,GómezFlores M,Mendez N,et al. New insights into HIV1primary skin disorders[J].J Int
AIDS Soc,2011 ,14:(5):1186-1758.
[2] 杨时瀚,李玉叶.HIV/AIDS 相关皮肤黏膜损害研究进展[J].皮肤病与性病,2013 ,35(3):141-144.
[3]Han J,Lun WH,Meng ZH,et al. Mucocutaneous manifestations of HIV-infected patients in the era of HAART in Guangxi
Zhuang Autonomous Region,China[J]. J Eur Acad Dermatol Venereol,2013 ,27(3):376-382.
[4] 张福杰.国家免费艾滋病抗病毒药物治疗手册[M].3版. 北京:人民卫生出版社,2012:109-117.
[5] 袁 静,李福民.中毒性表皮坏死松解症和Stevensjohnson 综合征[J].实用医院临床杂志,2012 ,9(4):207-209.
[6] Yang C,Mosam A,Mankahla A,et al. HIV infection predisposes skin to toxic epidermal necrolysis via depletion of skin-
directed CD4 T cells[J]. J Am Acad Dermatol,2014,70(6): 1096-1102.
[7] Paque.P,Meuwis MA,Mazzucchelli G ,et al .Proteomic Kinetic Analysis of Blister Fluid and Serum in a Patient with Drug
Induced Toxic Epidermal Necrolysis[J].A Comparison with Skin Immunohistochemistry,2012 ,7(5):339-51.
[8] 袁卫如,李卫平,郑捷,等.人类疱疹病毒6感染与药疹发病关系的研究[J].诊断学理论与实践,2009,8(3):317-314.
[9] Lichtenstein KA1,Armon C,Buchacz K ,et al.Initiation of antiretroviral therapy at CD4 cell counts >/=350 cells/mm
3 does not increase incidence or risk of peripheral neuropathy,anemia,or renal insufficiency[J].J Acquir Immune
Defic Syndr.,2008,47(1):27-35.
[10] 沈银忠,卢洪洲.2011版艾滋病抗病毒治疗指南解读[J].世界临床药物,2012,33(3):183-186.
[11] 魏武杰.乔树芳.重症药疹76例临床分析[J].中国皮肤性病学杂志,2012,26(5):403-405.
[12] 金永梅,白劲松,李玉叶,等.HIV/AIDS 合并药疹患者实验室资料和预后的相关性研究[J].皮肤病与性病,2013,35 (6):321-327.
相似文献/References:
[1]董文斌,赵金仙,李世福,等.未抗病毒治疗的HIV/AIDS患者 CD4+T淋巴细胞快速下降和显著下降比例及相关因素[J].中国皮肤性病学杂志,2018,(05):529.[doi:10.13735/j.cjdv.1001-7089.201709030]
DONG Wenbin,ZHAO Jinxian,LI Shifu,et al.Proportion of Rapid and Significant Decline of CD4+T Cell Counts Among Antiretroviral Treatment-naive HIV/AIDS Patients and Related Influencing Factors[J].The Chinese Journal of Dermatovenereology,2018,(11):529.[doi:10.13735/j.cjdv.1001-7089.201709030]
[2]蒋俊俊,梁浩,韦所苏,等.广西男性吸毒人群HIV感染的影响因素分析[J].中国皮肤性病学杂志,2013,(06):593.
JIANG Junjun,LIANG Hao,WEI Suosu,et al.Circumcision for Prevalent HIV Infection Among Male Drug Users in Guangxi,China: a Casecontrol Study[J].The Chinese Journal of Dermatovenereology,2013,(11):593.
[3]李倩如,刘萍萍,轩小燕,等.河南省采供血感染HIV长期不进展者T淋巴细胞亚群检测[J].中国皮肤性病学杂志,2013,(11):1124.
LI Qian-ru,LIU Ping-ping,XUAN Xiao-yan,et al.Detection on the T-lymphocyte Subpopulations in HIV-infected Long Term Nonprogressors among Former Blood Donors in Henan Province[J].The Chinese Journal of Dermatovenereology,2013,(11):1124.
[4]雷丽明,王华,彭兰.综合性医院1 267例AIDS/HIV感染情况分析[J].中国皮肤性病学杂志,2014,(12):1250.[doi:10.13735/j.cjdv.1001-7089.2014.1250]
LEI Li-ming,WANG Hua,PENG Lan.Analysis of 1 267 AIDS/HIV Cases in General Hospital[J].The Chinese Journal of Dermatovenereology,2014,(11):1250.[doi:10.13735/j.cjdv.1001-7089.2014.1250]
[5]皮肖冰,王继辉,欧阳菊香.2006-2012年佛山市某院441 867例住院患者HIV抗体筛查结果分析[J].中国皮肤性病学杂志,2014,(04):379.
PI Xiao bing,WANG Ji hui,OUYANG Ju xiang.Analysis of HIV Antibody Screening in 441 867 Inpatients of One Hospital of Foshan between 2006 and 2012[J].The Chinese Journal of Dermatovenereology,2014,(11):379.
[6]庞晓霞,陈兴鸿,覃海媚,等.HIV感染不同疾病进程IL-27和T淋巴细胞亚群的检测[J].中国皮肤性病学杂志,2018,(07):787.[doi:10.13735/j.cjdv.1001-7089.201712067]
PANG Xiaoxia,CHEN Xinghong,QIN Haimei,et al.Expression of IL-27 and T lymphocyte Subsets at Different Stages of HIV Infection[J].The Chinese Journal of Dermatovenereology,2018,(11):787.[doi:10.13735/j.cjdv.1001-7089.201712067]
[7]张鹏,蒋忠胜,李敏基,等.长期抗病毒治疗的艾滋病患者CD4+/CD8+比值影响因素分析[J].中国皮肤性病学杂志,2020,(03):290.[doi:10.13735/j.cjdv.1001-7089.201906095]
ZHANG Peng,JIANG Zhongsheng,LI Minji,et al.The Research of Impact Factors on CD4+/CD8+ Ratio in Long Term Treated HIV-infected Patients[J].The Chinese Journal of Dermatovenereology,2020,(11):290.[doi:10.13735/j.cjdv.1001-7089.201906095]